Market Overview

Morning Market Movers

Related GPRC
Kandi Technologies Says SEC Won't Act On Probe
Morning Market Losers
Related GERN
Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study
Omeros (OMER) Hits New 52-Week High on Positive FDA Decision

Celldex Therapeutics (NASDAQ: CLDX) surged 25.34% to $6.9190 at 9:54 am. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

Guanwei Recycling (NASDAQ: GPRC) climbed 25.15% to $2.09. Guanwei Recycling's trailing-twelve-month ROE is 33.04%.

Geron (NASDAQ: GERN) surged 24.53% to $1.32. Geron reported positive clinical results from the Phase 2 trial of imetelstat in patients with essential thrombocythemia.

Intermec (NYSE: IN) shares advanced 22.68% to $9.79. Honeywell International (NYSE: HON) announced its plans to buy Intermec for $600 million.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers


Related Articles (CLDX + GERN)

View Comments and Join the Discussion!